Interventional Oncology Devices Market - 2024-2033

July 2025 | 217 pages | ID: IBA78C5DAC68EN
DataM Intelligence

Abstracts

The Interventional Oncology Devices Market was valued at US$ 2.70 Billion in 2024 and is anticipated to reach US$ 5.00 Billion by 2033, at a CAGR of 0.071 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Interventional Oncology Devices Market.

This report delivers a comprehensive overview of the Interventional Oncology Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Interventional Oncology Devices Market. The Interventional Oncology Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Interventional Oncology Devices Market Scope:

Key Players

• Medtronic

Major Highlights

This report delivers a comprehensive overview of the Interventional Oncology Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Interventional Oncology Devices Market. The Interventional Oncology Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY PRODUCT TYPE

4.1. Snippet by Procedure
4.2. Snippet by Cancer Type
4.3. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Rising Demand For Minimally Invasive Procedures
    5.1.1.2. Increasing Global Cancer Incidence and Prevalence
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. Shortage of Well-trained and Skilled Radiologists and Oncologists
    5.1.2.2. Limited Awareness and Accessibility In Low-Income Regions
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Integration of AI And Robotics in Interventional Procedures
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established leaders with largest largest-selling Brand
  6.1.3. Market leaders with established Product Type
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
  6.5.1. North America
  6.5.2. Europe
  6.5.3. Asia Pacific
  6.5.4. South America
  6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Supply Chain Analysis
6.8. Patent Analysis
6.9. SWOT Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders

7. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET, BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Ablation Devices*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Radiofrequency (RF) Ablation Devices
  7.2.4. Microwave Ablation Devices
  7.2.5. Cryoablation Devices
  7.2.6. Others
7.3. Embolization Devices
  7.3.1. Radioembolic Agents
  7.3.2. Non-Radio embolic Agents
7.4. Support Devices
  7.4.1. Microcatheters
  7.4.2. Guidewires

8. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET, BY PROCEDURE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  8.1.2. Market Attractiveness Index, By Procedure
8.2. Thermal Tumor Ablation*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)?
8.3. Non-Thermal Tumor Ablation
8.4. Transcatheter Arterial Chemoembolization
8.5. Transcatheter Arterial
8.6. Transcatheter Arterial Embolization/Bland Embolization

9. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET, BY CANCER TYPE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  9.1.2. Market Attractiveness Index, By Cancer Type
9.2. Liver Cancer*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)?
9.3. Lung Cancer
9.4. Bone Metastasis
9.5. Kidney Cancer
9.6. Breast Cancer
9.7. Prostate Cancer
9.8. Others

10. GLOBAL INTERVENTIONAL ONCOLOGY DEVICES MARKET, BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)?
10.3. Clinics
10.4. Ambulatory Surgical Centers

11. INTERVENTIONAL ONCOLOGY DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

12. INTRODUCTION

12.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.1. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.7.1. U.S.
    12.2.7.2. Canada
    12.2.7.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.7.1. Germany
    12.3.7.2. U.K.
    12.3.7.3. France
    12.3.7.4. Spain
    12.3.7.5. Italy
    12.3.7.6. Rest of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.7.1. Brazil
    12.4.7.2. Argentina
    12.4.7.3. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.7.1. China
    12.5.7.2. India
    12.5.7.3. Japan
    12.5.7.4. South Korea
    12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

14. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

14.1. Market Share Analysis and Positioning Matrix
14.2. Strategic Partnerships, Mergers & Acquisitions
14.3. Key Developments in Product Type Portfolios and Innovations
14.4. Company Benchmarking

15. COMPANY PROFILES

15.1. Medtronic*
  15.1.1. Company Overview
  15.1.2. Product Type Portfolio
    15.1.2.1. Product Type Description
    15.1.2.2. Product Type Key Performance Indicators (KPIs)
    15.1.2.3. Historic and Forecasted Product Type Sales
    15.1.2.4. Product Type Sales Volume

16. FINANCIAL OVERVIEW

16.1. Company Revenue’s
  16.1.1. Geographical Revenue Shares
    16.1.1.1. Revenue Forecasts
  16.1.2. Key Developments
    16.1.2.1. Mergers & Acquisitions
    16.1.2.2. Key Product Type Development Activities
    16.1.2.3. Regulatory Approvals, etc.
  16.1.3. SWOT Analysis
16.2. Boston Scientific
16.3. BD
16.4. Terumo
16.5. Merit Medical
16.6. AngioDynamics
16.7. Johnson & Johnson
16.8. Teleflex
16.9. Cook Medical
16.10. HealthTronics (*LIST NOT EXHAUSTIVE)

17. ASSUMPTIONS AND RESEARCH METHODOLOGY

17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation

18. APPENDIX

18.1. About Us and Services
18.2. Contact Us